多组分干预对老年人营养不良的影响:一项多中心随机临床试验。
Effect of multicomponent intervention on malnutrition in older adults: A multicenter randomized clinical trial.
机构信息
Department of Geriatrics, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; Jiangsu Provincial Key Laboratory of Gerontology & Geriatrics, Nanjing 210029, China; Jiangsu Provincial Innovation Center of Gerontology & Geriatrics, Nanjing 210029, China.
Department of Geriatrics, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; Department of General Practice, The First People's Hospital of Lianyungang, Lianyungang Clinical College of Nanjing Medical University, Lianyungang 222000, China.
出版信息
Clin Nutr ESPEN. 2024 Apr;60:31-40. doi: 10.1016/j.clnesp.2024.01.004. Epub 2024 Jan 11.
BACKGROUND & AIMS: Malnutrition is a significant geriatric syndrome (GS) prevalent in older adults and seriously affects patient prognosis and quality of life. We assessed the impact of the multicomponent intervention of health education, dietary advice, and exercise with oral nutritional supplementation (ONS) on nutritional status, body composition, physical functions, and quality of life.
METHODS
This multicenter randomized clinical trial (RCT) was performed from April 2021 to April 2022. The intervention lasted for 12 weeks, and 99 older adults with malnutrition or at risk of malnutrition were enrolled in six nursing homes. All participants were randomly assigned to the control (health education plus standard diet plus exercise) or research (health education plus standard diet plus exercise plus ONS) group. The research group consumed ONS (244 kcal, 9.8g protein, and 9.6g fat per time) twice a day between meals. The primary outcomes were changes in the nutritional status and body composition from baseline to 12 weeks. The secondary outcomes were changes in physical function, quality of life and nutritional associated other blood markers.
RESULTS
For primary outcomes, after 12 weeks, body weight increased similarly in both treatment arms (time × treatment effect, P > 0.05). There were no between-group differences in body mass index (BMI) or mini nutritional assessment tool-short form (MNA-SF) scores (time × treatment effects, P > 0.05). The MNA-SF score from 11.0 (10.5, 12.0) to 13.0 (11.0, 13.0) in the research group and from 11.0 (10.0, 12.0) to 12.0 (11.0, 13.0) in the control group (both P < 0.05). There were no between-group differences in the skeletal muscle mass index (SMI), fat-free mass index (FFMI), appendicular skeletal muscle mass (ASMM), fat mass (FAT), or leg muscle mass (LMM) (time × treatment effects, P > 0.05). Both groups showed similar and highly significant increases in SMI, FFMI, and LMM after (P < 0.05). The research group showed an increase in fat-free mass (FFM) and ASMM and a decrease in the percent of body fat (PBF) and waist circumference (WC) (P < 0.05). For secondary outcomes, There were no between-group differences in grip strength, short physical performance battery (SPPB), 6-min walking distance (6MWD), activities of daily living (ADL), instrumental activities of daily living (IADL), frailty status (FRAIL), mini-mental state examination (MMSE), Tinetti, geriatric depression scale-15 (GDS-15), or 12-item short form survey (SF-12) (time × treatment effects, P > 0.05). Although there was no significant difference, the 6MWD changed differentially between the two treatment arms during the study period in favor of the research group. Although not significant, SF-12 scores improved after 12 weeks in both groups. No between-group differences were observed in prealbumin (PRE), c-reactive protein (CRP), vitamin D (VIT-D), insulin-like growth factor 1 (IGF-1), alanine transaminase (ALT), aspartate aminotransferase (AST), serum creatinine (Scr), interleukin-6 (IL-6), interleukin-10 (IL-10), tumor necrosis factor-α (TNF-α), insulin, and adiponectin levels (time × treatment effects, P > 0.05). Insulin and adiponectin levels were significantly higher in the control group (P < 0.05).
CONCLUSION
The twelve-week multicomponent intervention improved the nutritional status of older people in China at risk of malnutrition. ONS may enhance the effects of exercise on muscle mass. This clinical trial was registered (https://www.
CLINICALTRIALS
gov). The trial number is ChiCTR2000040343.
背景与目的
营养不良是老年人中常见的一种重大老年综合征(GS),严重影响患者的预后和生活质量。我们评估了健康教育、饮食建议和运动联合口服营养补充(ONS)对营养状况、身体成分、身体功能和生活质量的多组分干预的影响。
方法
这是一项多中心随机临床试验(RCT),于 2021 年 4 月至 2022 年 4 月进行。干预持续 12 周,共有 99 名有营养不良或营养不良风险的老年人被纳入六家养老院。所有参与者均被随机分配至对照组(健康教育+标准饮食+运动)或研究组(健康教育+标准饮食+运动+ONS)。研究组在两餐之间口服 ONS(244 千卡,9.8 克蛋白质和 9.6 克脂肪)两次。主要结局是从基线到 12 周时营养状况和身体成分的变化。次要结局是身体功能、生活质量和营养相关其他血液标志物的变化。
结果
对于主要结局,治疗 12 周后,两组的体重均有相似的增加(时间×治疗效果,P>0.05)。两组的体重指数(BMI)或迷你营养评估工具-简短形式(MNA-SF)评分无组间差异(时间×治疗效果,P>0.05)。研究组的 MNA-SF 评分从 11.0(10.5,12.0)增加到 13.0(11.0,13.0),对照组从 11.0(10.0,12.0)增加到 12.0(11.0,13.0)(均 P<0.05)。两组的骨骼肌质量指数(SMI)、无脂肪质量指数(FFMI)、四肢骨骼肌质量(ASMM)、脂肪质量(FAT)或腿部肌肉质量(LMM)均无组间差异(时间×治疗效果,P>0.05)。两组的 SMI、FFMI 和 LMM 均显著增加(P<0.05)。研究组的无脂肪量(FFM)和 ASMM 增加,体脂肪百分比(PBF)和腰围(WC)减少(P<0.05)。对于次要结局,两组握力、短体表现电池(SPPB)、6 分钟步行距离(6MWD)、日常生活活动(ADL)、工具性日常生活活动(IADL)、虚弱状态(FRAIL)、简易精神状态检查(MMSE)、Tinetti、老年抑郁量表-15(GDS-15)或 12 项简短形式调查(SF-12)评分均无组间差异(时间×治疗效果,P>0.05)。尽管没有显著差异,但在研究期间,6MWD 在两个治疗组之间的变化有利于研究组。尽管不显著,但两组的 SF-12 评分在 12 周后均有所改善。两组间前白蛋白(PRE)、C 反应蛋白(CRP)、维生素 D(VIT-D)、胰岛素样生长因子 1(IGF-1)、丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、血清肌酐(Scr)、白细胞介素-6(IL-6)、白细胞介素-10(IL-10)、肿瘤坏死因子-α(TNF-α)、胰岛素和脂联素水平均无差异(时间×治疗效果,P>0.05)。对照组的胰岛素和脂联素水平显著较高(P<0.05)。
结论
为期 12 周的多组分干预改善了中国有营养不良风险的老年人的营养状况。ONS 可能增强运动对肌肉质量的影响。这项临床试验已在(https://www.clinicaltrials.gov)注册。试验编号为 ChiCTR2000040343。